Taiantang pharmaceutical snake fat shenhuang ointment obtained new drug certificate and production approval

Guangdong taiantang Pharmaceutical Co., Ltd announced in the afternoon of January 22 that recently, the company received the new drug certificate and drug registration approval document of "snake fat shenhuang ointment" issued by the State Food and drug administration After examination, the drug met the relevant requirements of drug registration, and was approved for registration and production Taiantang said that the acquisition of the drug registration approval further enriched and optimized the company's products, further established the company's products in the Chinese medicine skin medicine market segment, and will have a positive impact on the company's product market expansion and business performance Tai'an Tang also announced that recently, the State Council issued the notice on the publication of the fourth batch of national intangible cultural heritage representative project list, and the "production technology of Qi Lin pill of Tai'an Tang" declared by Tai'an Tang was included in the National Intangible Cultural Heritage Representative project list extension project list This selection is conducive to the inheritance and dissemination of "taiantang Qilin pill making skills", and effective protection of intangible cultural heritage It will further establish the dominant position of taiantang's exclusive core product Qilin pill in the reproductive health and eugenics and eugenics subdivision fields, and will have a positive impact on the market expansion and business performance of the company's product Qilin pill.